Posts Tagged ‘Bleeding’

Ipsen’s Partner Inspiration Biopharmaceuticals Announces Non-Inferiority Of IB1001, Its Recombinant Factor IX For Hemophilia B

Pivotal Phase III Trial Showed PROMACTA(R) (eltrombopag Olamine) Raised Platelet Counts And Reduced Bleeding In Patients With Chronic ITP

New Biomedical Engineering Tools To Control Blood Loss

New Data To Be Presented At The World Federation Of Hemophilia 2010 Congress

ChemGenex’s Marketing Authorization Application For Omacetaxine Mepesuccinate Validated By The European Medicines Agency

New Treatment For Blood Clots In The Leg Tested In $10M Clinical Trial

US Food And Drug Administration Approves RECOTHROM™

Helixate FS Receives FDA Approval For Routine Prophylaxis In Children With Hemophilia A

Data From Phase III Comparative Study Show Campath(R) Superior To Chlorambucil As A First-line Therapy In B-CLL

JCI Table Of Contents: Oct. 25, 2010

Tag Cloud